So-Young to Report 2025 Financial Results

So-Young International Inc. (NASDAQ: SY), founded in 2013, operates as a leading online platform in China for medical aesthetics and consumption healthcare, connecting consumers and service providers. Their platform offers curated treatment information, online reservations, and high-quality treatments. The company also develops, produces, and distributes optoelectronic medical equipment and injectable products. So-Young's business model integrates professional content distribution through social media, a user-generated content social community, online reservation services, and the production of medical beauty equipment. Revenue is generated through information and reservation service fees from medical aesthetic service providers. As of March 2, 2026, So-Young's stock price was $3.13, with a market cap of $312 million and 100 million shares. The company faces competition from other business service companies such as NeoGenomics, Upbound Group, Donnelley Financial Solutions, LegalZoom.com, and Playtika. Headspace, Push Doctor, Halodoc, Doctor Insta, and Carbon Health are also considered competitors. Despite the competition, analysts have given So-Young a "Strong Buy" consensus rating, projecting an average 12-month price target of $7.752. China's aesthetic medicine market is experiencing substantial growth, with a projected revenue of $17.78 billion by 2033 and a CAGR of 14.3% from 2025 to 2033. So-Young is expanding into dental, dermatology, ophthalmology, gynecology, and physical examination services to capitalize on this growth. The company is headquartered in Beijing and has 1,800 employees.